257 related articles for article (PubMed ID: 5820567)
1. Mafenide (Sulfamylon) and other topical agents for severe burns.
Med Lett Drugs Ther; 1969 Aug; 11(17):69-70. PubMed ID: 5820567
[No Abstract] [Full Text] [Related]
2. [Chemoprophylaxis in severe burns. Experience with sulfamylon acetate].
Müller FE
Munch Med Wochenschr; 1969 Apr; 111(17):1000-6. PubMed ID: 5818970
[No Abstract] [Full Text] [Related]
3. Silver sulfadiazine cream in the management of burns.
Grossman AR
Am Fam Physician GP; 1970 Feb; 1(2):69-75. PubMed ID: 5262928
[No Abstract] [Full Text] [Related]
4. [Local treatment of burns: analysis of the use of antimicrobial agents].
Mariani U; Pinto WS; Pinto DC
Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(2):69-75. PubMed ID: 8235276
[TBL] [Abstract][Full Text] [Related]
5. Mafenide acetate cream: a review.
Drugs; 1971; 1(6):434-60. PubMed ID: 4948236
[No Abstract] [Full Text] [Related]
6. Sliver sulfadiazine.
Med Lett Drugs Ther; 1974 May; 16(10):43-4. PubMed ID: 4830298
[No Abstract] [Full Text] [Related]
7. Management of thermal burns with Sulfamylon.
Allen BD
Keisei Geka; 1970 Jan; 13(1):38-9. PubMed ID: 5462475
[No Abstract] [Full Text] [Related]
8. Burn wound sepsis: effect of delayed treatment with topical chemotherapy on survival.
Salisbury RE; Bevin AG; Steinkraus GE; Enterline DS
J Trauma; 1980 Feb; 20(2):120-2. PubMed ID: 7354493
[TBL] [Abstract][Full Text] [Related]
9. Topical chemotherapy and burn wound care.
Luterman A
Ann Chir Gynaecol; 1980; 69(5):210-2. PubMed ID: 7469376
[No Abstract] [Full Text] [Related]
10. Bacteriological and clinical studies on sulfamylon in the treatment of burns.
Rudowski W; Brudzynska-Charewicz S; Zietkiewicz W; Nasilowski W; Serafinska D; Bukowska D
Br J Plast Surg; 1972 Apr; 25(2):135-40. PubMed ID: 4260061
[No Abstract] [Full Text] [Related]
11. Topical therapy for control of bacteria in the burn wound.
Moncrief JA
World J Surg; 1978 Mar; 2(2):151-65. PubMed ID: 676330
[No Abstract] [Full Text] [Related]
12. [Experiences in the local treatment of burns].
Keil HR
Med Welt; 1970 Mar; 11():445-7. PubMed ID: 5439158
[No Abstract] [Full Text] [Related]
13. Immunological control of Pseudomonas infection in burn patients: a clinical evaluation.
Alexander JW; Fisher MW; MacMillan BG
Arch Surg; 1971 Jan; 102(1):31-5. PubMed ID: 4992359
[No Abstract] [Full Text] [Related]
14. The management of burns under conditions of limited resources using topical aqueous sulfamylon (mafenide) hydrochloride spray.
Mendelson JA
J Burn Care Rehabil; 1997; 18(3):238-44. PubMed ID: 9169948
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological modulation of wound healing in experimental burns.
Jurjus A; Atiyeh BS; Abdallah IM; Jurjus RA; Hayek SN; Jaoude MA; Gerges A; Tohme RA
Burns; 2007 Nov; 33(7):892-907. PubMed ID: 17521821
[TBL] [Abstract][Full Text] [Related]
16. Advances in the control of infection in burns.
Lowbury EJ
Br J Plast Surg; 1967 Apr; 20(2):211-7. PubMed ID: 6025585
[No Abstract] [Full Text] [Related]
17. Burn wound management.
Fernando J
Ceylon Med J; 1976 Mar; 21(1):70-8. PubMed ID: 975415
[No Abstract] [Full Text] [Related]
18. Sulfamylon therapy in severe burns: two hundred forty-six cases compared to previous experience.
Haynes BW; Gayle WE; Madge GE
Ann Surg; 1969 Oct; 170(4):696-704. PubMed ID: 5394447
[No Abstract] [Full Text] [Related]
19. Allergic contact dermatitis to mafenide acetate: a case series and review of the literature.
Firoz EF; Firoz BF; Williams JF; Henning JS
J Drugs Dermatol; 2007 Aug; 6(8):825-8. PubMed ID: 17763614
[TBL] [Abstract][Full Text] [Related]
20. Experimental burn wound sepsis: variations in response to topical agents.
Krizek TJ; Cossman DV
J Trauma; 1972 Jul; 12(7):553-62. PubMed ID: 4625533
[No Abstract] [Full Text] [Related]
[Next] [New Search]
